Total Payments
$573.74
2024 Payments
$45.55
Companies
14
Transactions
31
Payment Breakdown by Category
Food & Beverage$573.74 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $573.74 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $75.49 | 4 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $68.27 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $59.30 | 4 | $0 (2021) |
| PFIZER INC. | $57.27 | 4 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $47.39 | 3 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $47.26 | 2 | $0 (2019) |
| Incyte Corporation | $46.14 | 2 | $0 (2023) |
| Jazz Pharmaceuticals Inc. | $39.92 | 2 | $0 (2020) |
| Shire North American Group Inc | $38.07 | 2 | $0 (2019) |
| AbbVie Inc. | $24.18 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45.55 | 2 | Alexion Pharmaceuticals, Inc. ($45.55) |
| 2023 | $46.14 | 2 | Incyte Corporation ($46.14) |
| 2021 | $57.29 | 3 | AbbVie Inc. ($24.18) |
| 2020 | $203.40 | 12 | Janssen Pharmaceuticals, Inc ($58.31) |
| 2019 | $221.36 | 12 | Otsuka America Pharmaceutical, Inc. ($47.26) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.26 | General |
| 10/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Rare Disease | ||||||
| 09/08/2023 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: Oncology | ||||||
| 06/24/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $29.94 | General |
| Category: Hematology/Oncology | ||||||
| 10/28/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/17/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Cardiovascular | ||||||
| 02/25/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/09/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.18 | General |
| Category: Cardiovascular | ||||||
| 07/30/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Oncology | ||||||
| 03/13/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/27/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/26/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ADYNOVATE (Biological) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: HEMATOLOGY | ||||||
| 01/31/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Vitrakvi | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Oncology | ||||||
| 01/21/2020 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/17/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug), XYREM | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: NEUROLOGY | ||||||
| 01/15/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: Cardiovascular | ||||||
| 12/16/2019 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: PAIN | ||||||
| 11/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: DIABETES | ||||||
| 09/09/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEPHROLOGY | ||||||
| 08/28/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Immunology | ||||||
About Dr. Yugandhara Kate, MD
Dr. Yugandhara Kate, MD is a Hematology & Oncology healthcare provider based in Nashua, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1528544236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yugandhara Kate, MD has received a total of $573.74 in payments from pharmaceutical and medical device companies, with $45.55 received in 2024. These payments were reported across 31 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($573.74).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Nashua, NH
- Active Since 07/16/2018
- Last Updated 06/06/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1528544236
Products in Payments
- XARELTO (Drug) $75.49
- ELIQUIS (Drug) $47.39
- SAMSCA (Drug) $47.26
- XELJANZ (Drug) $43.84
- SUNOSI (Drug) $39.92
- ADYNOVATE (Biological) $32.85
- JARDIANCE (Drug) $29.96
- JAKAFI (Drug) $29.94
- SPIRIVA RESPIMAT (Drug) $29.34
- DALVANCE (Drug) $24.18
- SOLIRIS (Drug) $22.72
- ULTOMIRIS (Biological) $22.29
- Stivarga (Drug) $20.26
- DARZALEX (Biological) $18.73
- BRILINTA (Drug) $18.50
- GATTEX (Drug) $18.18
- MONJUVI (Drug) $16.20
- CHANTIX (Drug) $13.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Nashua
Nancy Chun, Md, MD
Hematology & Oncology — Payments: $7,026
Hematology & Oncology $7,026
Dr. Gautami Rao, M.d.,, M.D.,
Hematology & Oncology — Payments: $329.98
Hematology & Oncology $329.98
Can Wang
Hematology & Oncology — Payments: $107.82
Hematology & Oncology $107.82
Dr. Mary Voltz, M.d, M.D
Hematology & Oncology — Payments: $102.76
Hematology & Oncology $102.76